Jupiter Neurosciences (JUNS) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

JUNS Jupiter Neurosciences

Watchlist

4.400
+0.130+3.04%

Close Jan 17 16:00 ET

4.400
0.0000.00%

Post 18:55 ET

145.66MMarket Cap-107.32P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Jupiter Neurosciences Inc Trading Halted, Volatility Trading Pause
TipRanksJan 14 11:30 ET
Jupiter Neurosciences Announces Strategic Focus On NLRP3 Inflammasome Targeting In Clinical Trials For Neurodegenerative Diseases With JOTROL Platform
BenzingaJan 13 08:31 ET
Express News | Jupiter Neurosciences Announces Strategic Focus on Nlrp3 Pathway in Future Jotrol™ Trials
ReutersJan 13 08:01 ET
Jupiter Neurosciences | 10-Q: Quarterly report
SECDec 23, 2024 16:51 ET · Announcements
Greenridge Global Initiates Jupiter Neurosciences(JUNS.US) With Buy Rating, Announces Target Price $30
Moomoo NewsDec 20, 2024 13:31 ET · Ratings
Jupiter Neurosciences Initiated With a Buy at Greenridge
TipRanksDec 19, 2024 10:25 ET · Ratings

Comments

Jaguar8

Jan 13 07:13

NEWS

$Jupiter Neurosciences (JUNS.US)$
Jupiter Neurosciences Announces Strategic Focus on NLRP3 Pathway in Future JOTROL™ Trials
Monday, 13th January at 8:00 am
Jupiter, Florida, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Jupiter Neurosciences, Inc. (NASDAQ: JUNS) ("Jupiter" or the "Company"), a clinical-stage pharmaceutical company developing JOTROL™, a patented resveratrol-based platform, today announced a strategic focus on targeting the NLRP3 inflammasome in all upcoming clinical trials. This shift ai...

Mcsnacks H Tupack

Jan 12 19:20

Signaling a run

$Jupiter Neurosciences (JUNS.US)$ As long as it holds the 8.50 support which it has bounced off of 3 times it is headed to 20.00. Buy in 8.55. Sell 20.00. Stop-loss 8.49. Easiest stop-loss to set because if it falls below 8.50 during market hours it is going to fall down to the low.

Stock_Drift

Dec 27, 2024 06:02

☕️ 💭

$Jupiter Neurosciences (JUNS.US)$

Mcsnacks H Tupack

Dec 19, 2024 16:16

News

$Jupiter Neurosciences (JUNS.US)$
Entered into a Strategic Services Agreement with Dominant Treasure Health Company Limited. Pursuant to the terms of the Dominant Treasure Agreement, Dominant Treasure agreed to provide certain services to the Company to assist the Company in accelerating the Company’s desire to get its products developed and distributed in the Southeast Asian market. In exchange for Dominant Treasure’s services pursuant to the Dominant Treasure Agreement, the Company agreed...